Literature DB >> 29529609

Risk Factors and Clinical Impact of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: Analysis from the China National Stroke Registry.

Wanying Duan1,2,3,4, Yuesong Pan1,2,3,4,5, Chunjuan Wang1,2,3,4, Yilong Wang1,2,3,4, Xingquan Zhao1,2,3,4, Yongjun Wang1,2,3,4, Liping Liu1,2,3,4.   

Abstract

BACKGROUND: Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) is a significant cause of morbidity and mortality. While it is important to detect early signs of DCI, patients with high risk of DCI are difficult to identify, and the potential risk factors are uncertain. This study aimed to identify independent risk factors of DCI and clarify their clinical impact on outcome and the disease course.
METHODS: For this nationwide, multicenter, prospective clinical study involving consecutive patients with aSAH recruited from the China National Stroke Registry, demographic, clinical, radiological, and laboratorial data during hospitalisation, in-hospital complications, functional outcomes, and mortality at 3, 6, and 12 months were recorded. Using univariate and multivariate logistic regression to determine risk factors associated with the development of DCI, the contribution of DCI to short- and long-term outcomes was evaluated.
RESULTS: Of all 504 patients with aSAH, 155 developed DCI. Multivariate analysis revealed that being female, a history of diabetes mellitus, a Hunt and Hess grade of 4-5, and a World Federation of Neurosurgical Societies grade of IV-V were independent risk factors of DCI. DCI was associated with high in-hospital complications, and with a high utilization rate of supporting interventions. DCI also contributed to poorer functional outcome and higher mortality at discharge and after 3, 6, and 12 months.
CONCLUSIONS: Female sex, a history of diabetes mellitus, and poor clinical grade are independent early risk factors for the development of DCI and can contribute to a better identification of patients at a high risk for DCI. DCI was associated with severe clinical course, poor outcome, and mortality both in the short- and long-term in patients with aSAH in China.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Aneurysmal subarachnoid hemorrhage; Delayed cerebral ischemia; Outcome; Risk factors

Mesh:

Year:  2018        PMID: 29529609     DOI: 10.1159/000487325

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  18 in total

1.  Sex differences in aneurysmal subarachnoid haemorrhage (aSAH): aneurysm characteristics, neurological complications, and outcome.

Authors:  Sabah Rehman; Ronil V Chandra; Kevin Zhou; Darius Tan; Leon Lai; Hamed Asadi; Jens Froelich; Nova Thani; Linda Nichols; Leigh Blizzard; Karen Smith; Amanda G Thrift; Christine Stirling; Michele L Callisaya; Monique Breslin; Mathew J Reeves; Seana Gall
Journal:  Acta Neurochir (Wien)       Date:  2020-06-30       Impact factor: 2.216

2.  The Association Between Serum Macrophage Migration Inhibitory Factor and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Xiaobo Yang; Jianhua Peng; Jinwei Pang; Weifeng Wan; Chuanhong Zhong; Tangming Peng; Kunyang Bao; Yong Jiang
Journal:  Neurotox Res       Date:  2019-07-02       Impact factor: 3.911

3.  The effect of sex differences on complications and 90-day outcomes after aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis.

Authors:  Runting Li; Fa Lin; Yu Chen; Junlin Lu; Jun Yang; Heze Han; Kexin Yuan; Ke Wang; Debin Yan; Ruinan Li; Shihao He; Zhipeng Li; Haibin Zhang; Xiheng Chen; Li Ma; Yahui Zhao; Qiang Hao; Xun Ye; Hao Wang; Hongliang Li; Linlin Zhang; Guangzhi Shi; Jianxin Zhou; Youxiang Li; Shuo Wang; Xiaolin Chen; Yuanli Zhao
Journal:  Neurosurg Rev       Date:  2022-07-23       Impact factor: 2.800

4.  Comparison of Conventional Logistic Regression and Machine Learning Methods for Predicting Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Multicentric Observational Cohort Study.

Authors:  Ping Hu; Yuntao Li; Yangfan Liu; Geng Guo; Xu Gao; Zhongzhou Su; Long Wang; Gang Deng; Shuang Yang; Yangzhi Qi; Yang Xu; Liguo Ye; Qian Sun; Xiaohu Nie; Yanqi Sun; Mingchang Li; Hongbo Zhang; Qianxue Chen
Journal:  Front Aging Neurosci       Date:  2022-06-17       Impact factor: 5.702

5.  The association between serum adipocyte fatty acid-binding protein and 3-month disability outcome after aneurysmal subarachnoid hemorrhage.

Authors:  Yong-Gang Luo; Bing Han; Tong-Wen Sun; Xianzhi Liu; Jun Liu; Jun Zhang
Journal:  J Neuroinflammation       Date:  2020-02-19       Impact factor: 8.322

6.  Early stage neuroglobin level as a predictor of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Chenyu Ding; Dezhi Kang; Pengqiang Chen; Ziliang Wang; Yuanxiang Lin; Dengliang Wang; Zhangya Lin; Jianjun Gu
Journal:  Brain Behav       Date:  2020-02-05       Impact factor: 2.708

7.  Dynamic Change in Mean Platelet Volume and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Liuwei Chen; Quanbin Zhang
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

8.  DCI after Aneurysmal Subarachnoid Hemorrhage Is Related to the Expression of MFG-E8.

Authors:  Xianjun Chen; Yong'an Jiang; Jiayu Liu; Changfeng Wang; Dengfeng Wan; Ai'jun Liang; Jingxing Leng; Yu Yang; Hui Xiang; Ru'en Liu
Journal:  Biomed Res Int       Date:  2021-12-31       Impact factor: 3.411

9.  Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 as a biomarker of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Qun Lin; Hua-Jun Ba; Jun-Xia Dai; Jun Sun; Chuan Lu; Mao-Hua Chen; Xian-Dong Chen; Jian-Yong Cai
Journal:  Brain Behav       Date:  2020-01-14       Impact factor: 2.708

10.  Identification of Differentially-Methylated Genes and Pathways in Patients with Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage.

Authors:  Bong Jun Kim; Dong Hyuk Youn; In Bok Chang; Keunsoo Kang; Jin Pyeong Jeon
Journal:  J Korean Neurosurg Soc       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.